Cutting edge biomedical research and production require a sterile culture environment. Caron’s unique hydrogen peroxide chamber sterilization system provides just that, in a fast, dry process with no extra cleanup. This Caron innovation has now been recognized by US Patent #10,738,271.
This patent covers several unique features, including rapid cycle management, a highly repeatable sensor driven process, and a compact & effective sterilant catalyst system. This technology is unique to Caron and is fully scalable from small stackable CO2 incubators (the 5 ft3. (142L) Wally) to large reach-in units (25 & 33 ft3 (708 & 934L)).
“CO2 incubator sterilization is just the latest in a continued stream of Caron innovation”, commented Steve Keiser, Caron President & CEO. “Helping customers quickly transition from one culture run to another supports rapid and repeatable therapy delivery.”